Work

Clinical trial of the novel structure proteasome inhibitor NPI-0052 in patients with relapsed and relapsed/refractory multiple myeloma (r/r MM)

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.8505

Authors: C. C. Hofmeister, P. Richardson, T. Zimmerman, M. A. Spear, M. A. Palladino, A. M. Longenecker, G. F. Cropp, G. K. Lloyd, A. L. Hannah, K. Anderson

Institutions: University of Chicago, Dana-Farber Cancer Institute, The Ohio State University

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2244830292

Cites:

Cited by: 13

Related to: 10